ATS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
Rodney C.G. Franklin
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Pratap, U.
Right arrow Articles by Franklin, R. C.G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Pratap, U.
Right arrow Articles by Franklin, R. C.G.
Related Collections
Right arrow Cardiac - other

Ann Thorac Surg 2001;72:1740-1742
© 2001 The Society of Thoracic Surgeons

Case report

Octreotide to treat postoperative chylothorax after cardiac operations in children

Usha Pratap, MD, MRCPa, Zdenek Slavik, MD, FRCPCHa, Victor D. Ofoe, MRCPa, Obed Onuzo, MRCPa, Rodney C.G. Franklin, MD, FRCPCH*a

a Paediatric Surgical Unit, Harefield Hospital, Royal Brompton and Harefield NHS Trust, Harefield, Middlesex, United Kingdom

Accepted for publication December 28, 2000.

* Address reprint requests to Dr Franklin, Pediatric Cardiology, Harefield Hospital, Hill End Rd, Harefield, Middlesex UB9 6JH, United Kingdom
e-mail: r.franklin{at}rbh.nthames.nhs.uk

Chylothorax after pediatric cardiac operations is associated with significant morbidity and increased hospitalization. An octreotide (a synthetic somatostatin analogue) infusion (1 to 4 µg/kg per hour) with medium-chain triglyceride diet or parenteral nutrition was used in 4 pediatric cardiac surgical patients after chylothorax was diagnosed. Resolution followed within 5 days in all without recurrence, while on a normal diet.




This article has been cited by other articles:


Home page
 Ann. Thorac. Surg.Home page
S.-y. Chan, W. Lau, W. H.S. Wong, L.-c. Cheng, A. K.T. Chau, and Y.-f. Cheung
Chylothorax in Children After Congenital Heart Surgery
Ann. Thorac. Surg., November 1, 2006; 82(5): 1650 - 1656.
[Abstract] [Full Text] [PDF]

Home page
 Ann. Thorac. Surg.Home page
E. H. Chan, J. L. Russell, W. G. Williams, G. S. Van Arsdell, J. G. Coles, and B. W. McCrindle
Postoperative Chylothorax After Cardiothoracic Surgery in Children
Ann. Thorac. Surg., November 1, 2005; 80(5): 1864 - 1870.
[Abstract] [Full Text] [PDF]

Home page
 Asian Cardiovasc. Thorac. Ann.Home page
A. A Gomez-Caro, F. J Moradiellos Diez, C. F Marron, E. J Larru Cabrero, and J. L Martin de Nicolas
Conservative Management of Postsurgical Chylothorax with Octreotide
Asian Cardiovasc Thorac Ann, September 1, 2005; 13(3): 222 - 224.
[Abstract] [Full Text] [PDF]

Home page
 Ann. Thorac. Surg.Home page
S. M. Lagarde, J. M.T. Omloo, K. de Jong, O. R.C. Busch, H. Obertop, and J. J. B. van Lanschot
Incidence and Management of Chyle Leakage After Esophagectomy
Ann. Thorac. Surg., August 1, 2005; 80(2): 449 - 454.
[Abstract] [Full Text] [PDF]

Home page
 Ann. Thorac. Surg.Home page
J. Tibballs, R. Soto, and T. Bharucha
Management of newborn lymphangiectasia and chylothorax after cardiac surgery with octreotide infusion
Ann. Thorac. Surg., June 1, 2004; 77(6): 2213 - 2215.
[Abstract] [Full Text] [PDF]

Home page
 The Annals of PharmacotherapyHome page
S. A Al-Zubairy and A. S Al-Jazairi
Octreotide as a Therapeutic Option for Management of Chylothorax
Ann. Pharmacother., May 1, 2003; 37(5): 679 - 682.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 2001 by The Society of Thoracic Surgeons.